Stocks
Shire plcSHPG
NASDAQHealthcareBiotechnology$179.20+0.00%
A biopharmaceutical company focused on treatments for rare diseases and specialty conditions, with key franchises in immunology, hematology, neuroscience, and genetic disorders. Its portfolio historically included therapies such as Vyvanse for ADHD and a range of products targeting hereditary angioe...
Market Cap: $052W Range: $123.73 – $182.47
Congressional Interest in Shire plc (SHPG)
8 members of Congress have disclosed 33 trades in Shire plc (SHPG), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
33
Unique Politicians
8
Buys
24
Sells
9
Who in Congress Is Trading SHPG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-02-04 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-02-04 | JAMES B. RENACCI | buy | $1K – $15K |